Andrew Cooper

Stock Analyst at Raymond James

(0)
# 3296
Out of 5,287 analysts
159
Total ratings
45.83%
Success rate
0.85%
Average return
24 Stocks
Name Action Price Target Current % Upside Ratings Updated
Myriad Genetics
Reiterates: Outperform
27 19
10 90% 4 Feb 25, 2025
Guardant Health
Reiterates: Outperform
39 59
46.74 26.23% 3 Feb 21, 2025
Avantor
Reiterates: Outperform
26 24
16.53 45.19% 14 Feb 10, 2025
Haemonetics
Reiterates: Strong Buy
120 115
64.53 78.21% 8 Feb 7, 2025
Hologic
Reiterates: Outperform
95 90
61.89 45.42% 11 Feb 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
650 667
520.12 28.24% 6 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
140 145
108.59 33.53% 7 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 8 Feb 3, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Market Perform
n/a
n/a n/a 8 Sep 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 16 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
68 85
153.94 -44.78% 5 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
100 76
36.55 107.93% 12 Feb 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1 1
n/a n/a 10 Aug 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Market Perform
n/a
n/a n/a 1 Jul 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 14 May 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 7 May 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 8 Jan 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
45
16.95 165.49% 1 Nov 18, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 5 Sep 22, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
n/a
n/a n/a 4 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
31 39
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
145 225
n/a n/a 4 Feb 24, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Strong Buy
20
n/a n/a 1 Mar 18, 2020